Axitinib inhibition of [18F] fluorothymidine (FLT) uptake in patients (pts) with colorectal cancer (CRC): Implications for cytotoxic chemotherapy combinations.
C. Hoh
Consultant or Advisory Role - Pfizer (U)
Research Funding - Pfizer
J. R. Infante
No relevant relationships to disclose
H. A. Burris
No relevant relationships to disclose
J. C. Tarazi
Employment or Leadership Position - Pfizer
S. Kim
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
B. Rosbrook
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
T. R. Reid
No relevant relationships to disclose